Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methycyclohexylamino)-pyrimidine-5-carboxamide,compositions thereof and methods of their use
CA3019105A1
Solid forms of (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9h-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use
US2017281633A1
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
AU2016244228A1
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
WO2017011720A1
Solod forms 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d] oxazol-6-yl)17h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
WO2016205304A1
Methods of treatment using substituted diaminopyrimidyl compounds
EP3250557A1
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
EP3233809A1
Formulations of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methycyclohexylamino)-pyrimidine-5-carboxamide
WO2016100308A1
Methods for measurement of inhibition of c-jun n-terminal kinase in skin
CN107001372A
Substituted adenine phosphate compound, its composition and its treatment method
AU2015213397A1
Treatment of cancer with TOR kinase inhibitors
AU2015213400A1
Treatment of cancer with TOR kinase inhibitors
AU2015289929A1
Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof
AU2015201807A1
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methocyclohexyl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one, a solid form thereof and methods of their use
ZA201502294B
Treatment of cancer with tor kinase inhibitors
AU2015201138A1
Treatment of cancer with TOR kinase inhibitors
AU2015201030A1
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
AU2015200318A1
Treatment of cancer with TOR kinase inhibitors
AU2014369031A1
Substituted Diaminopyrimidyl Compounds, compositions thereof, and methods of treatment therewith
MX2016004212A
A tor kinase inhibitor in the prevention or treatment of cancer characterized by gene mutations.
